BFLY

Butterfly NetworkC

NYSE / Health Care Equipment & Services

At close

2026-06-03

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

30%

Probability

Target price

$6.80

+54.9% vs current

Most likely

Base case

45%

Probability

Target price

$5.50

+25.3% vs current

B-

Bear case

25%

Probability

Target price

$4.10

-6.6% vs current

AI sentiment snapshot

Latest data as of 2026-05-03

AI commentary

This T+3 follow-up still looks like a cautious monitoring setup, but the earnings release improved the near-term tone. The immediate reaction was positive in market coverage, and the May 1, 2026 anchor close of $5.40 leaves the stock only modestly below the packet's $5.56 median target, implying some of the beat and guidance reaffirmation was absorbed quickly. The main gap is that clear delayed analyst revisions were not readily available from checked sources, so confidence should not be upgraded solely from the first post-print move. [#8-K-2026-04-30]

RankAlpha Sentiment Codex - 2026-05-03

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-31eventQ1 beat and full-year reaffirmation improved near-term credibilityHigh impact

Butterfly's April 30, 2026 earnings release reported Q1 revenue of $26.5 million, up 25% year over year, gross margin of 68.9%, adjusted EBITDA loss of $6.1 million, and reaffirmed FY2026 revenue guidance of $117 million to $121 million while adding Q2 revenue guidance of $27 million to $31 million. That combination supports a constructive post-earnings read, but with the stock already near the median target the main question is whether the stronger print can hold through the next few weeks of digestion rather than simply produce a one-day bounce. [#8-K-2026-04-30]

2026-08-15catalystRevenue concentration and still-lossmaking execution keep the setup fragileHigh impact

The Q1 2026 10-Q shows cash and cash equivalents of $138.0 million, but the company still posted a $12.7 million net loss and one customer accounted for more than 10% of quarterly revenue. That leaves BFLY exposed if embedded licensing momentum moderates, enterprise conversions slip, or the planned Home & Community Care rollout takes longer to commercialize. [#10-Q-2026-04-30]

2026-09-30catalystHome & Community Care and enterprise software milestones are the clearest next growth proof pointsHigh impact

Management said it is progressing toward a first Home & Community Care commercial agreement in the first half of 2026 with an initial statewide deployment expected in the third quarter, while also citing a first enterprise deal of the year and continued software pipeline growth. If those milestones convert into recurring revenue and broader workflow adoption, investors could give more weight to Butterfly's platform narrative beyond probe sales. [#8-K-2026-04-30] [#10-K-2026-02-27]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-03 • Updated nightlySource: Internal modelMethodology